Swixx Biopharma OÜ
- Registry code
- 12741121
- VAT number
- EE101811486
- Address
- Harju maakond, Tallinn, Kesklinna linnaosa, Pärnu mnt 139e/2, 11317
- Registered
- 23.10.2014 · 11 yrs
- Activity
- Other business support service activities n.e.c. 82991
- Capital
- 2 500 €
- e•••@s•••.comLog in to see
- Phone
- +372 •• ••••Log in to see
- Website
- www.swixxbiopharma.com from email
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
4 persons
| Board 4 | ||
|---|---|---|
| Dezső Dr. Mártha1 companyno tax debt | 22.08.1977 (49 a)Personal ID ↗ | 22.09.2023 |
| Laur Saar2 companiesno tax debt | Personal ID ↗ | 22.09.2023 |
| Piret Tuul3 companiesno tax debt | Personal ID ↗ | 02.07.2024 |
| Rima Jankovska1 companyno tax debt | 13.05.1972 (54 a)Personal ID ↗ | 07.04.2022 |
| Shareholders 1 | ||
| Swixx Biopharma AG | 100,0% 2 500 € | 01.09.2023 |
| Beneficial owners 2 | ||
| Barry Bahram SiadatMuul viisil kontroll või mõju (lepingulised, perekondlikud vm suhted) | 23.07.2026 | |
| Jamshid Mark KeynejadMuul viisil kontroll või mõju (lepingulised, perekondlikud vm suhted) | 23.07.2026 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 1 286 808 € | ▲ 24% | 425 116 € | 412 194 € | 27 |
| 2026 Q1 | 1 225 898 € | ▲ 25% | 268 853 € | 261 274 € | 27 |
| 2025 Q4 | 1 307 026 € | ▲ 25% | 283 650 € | 283 731 € | 26 |
| 2025 Q3 | 1 063 445 € | ▲ 6% | 258 986 € | 256 268 € | 26 |
| 2025 Q2 | 1 040 940 € | ▼ 7% | 244 865 € | 249 760 € | 25 |
| 2025 Q1 | 983 739 € | ▲ 5% | 379 593 € | 354 731 € | 24 |
| 2024 Q4 | 1 048 033 € | ▲ 12% | 230 369 € | 223 198 € | 25 |
| 2024 Q3 | 1 000 727 € | ▲ 18% | 231 966 € | 224 127 € | 24 |
| 2024 Q2 | 1 120 457 € | ▲ 23% | 195 307 € | 200 585 € | 24 |
| 2024 Q1 | 936 353 € | ▲ 15% | 281 286 € | 275 613 € | 24 |
| 2023 Q4 | 936 100 € | ▲ 7% | 193 387 € | 194 331 € | 23 |
| 2023 Q3 | 845 773 € | ▲ 13% | 183 714 € | 183 757 € | 23 |
Show full history (18 quarters)
| 2023 Q2 | 914 534 € | ▲ 23% | 254 335 € | 252 817 € | 22 |
| 2023 Q1 | 814 318 € | ▲ 50% | 176 609 € | 174 388 € | 23 |
| 2022 Q4 | 878 807 € | 177 744 € | 184 870 € | 23 | |
| 2022 Q3 | 748 826 € | 160 860 € | 157 738 € | 24 | |
| 2022 Q2 | 745 699 € | 152 097 € | 147 551 € | 21 | |
| 2022 Q1 | 541 136 € | 145 289 € | 137 766 € | 22 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2025 | 2024 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | 4,4 m € | ▲ 10% | 4,0 m € | ▲ 34% | 3,0 m € | ▲ 264% | 822 k € |
| Profit | 346 k € | ▲ 67% | 207 k € | ▲ 32% | 157 k € | ▲ 286% | 40 650 € |
| Profit margin | 7,8% | 5,2% | 5,3% | 4,9% | |||
| Retained earnings | 685 k € | ▲ 43% | 479 k € | ▲ 229% | 146 k € | ▲ 39% | 105 k € |
| Cash | 166 k € | ▼ 38% | 267 k € | ▲ 109% | 128 k € | ▲ 189% | 44 229 € |
| Current assets | 1,6 m € | ▲ 37% | 1,2 m € | ▲ 84% | 642 k € | ▲ 147% | 260 k € |
| Fixed assets | 20 685 € | ▼ 10% | 22 999 € | ▼ 38% | 36 962 € | ▼ 1% | 37 267 € |
| Assets | 1,6 m € | ▲ 36% | 1,2 m € | ▲ 78% | 679 k € | ▲ 128% | 297 k € |
| Current liabilities | 609 k € | ▲ 17% | 518 k € | ▲ 39% | 373 k € | ▲ 151% | 149 k € |
| Total liabilities | 609 k € | ▲ 17% | 518 k € | ▲ 39% | 373 k € | ▲ 151% | 149 k € |
| Equity | 1,0 m € | ▲ 50% | 688 k € | ▲ 125% | 305 k € | ▲ 106% | 148 k € |
| Labour costs | -2,7 m € | ▼ 12% | -2,4 m € | ▼ 38% | -1,7 m € | ▼ 226% | -530 k € |
| Employees | 27 | ▲ 8% | 25 | ▲ 25% | 20 | ▲ 233% | 6 |
| Filed | 16.06.2026 | 27.06.2025 | 02.06.2023 | 09.06.2022 | |||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Other business support service activities n.e.c. main activity | 82991 | 4 406 198 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
3
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Other business support service activities n.e.c.
20
| # | Company | Revenue |
|---|---|---|
| 1 | Paide Salvestusjaam OÜ | 10,3 m € |
| 2 | Wolt Eesti OÜ | 8,4 m € |
| 3 | AstraZeneca Eesti OÜ | 7,0 m € |
| 4 | AbbVie OÜ | 6,3 m € |
| 5 | Mindvalley OÜ | 5,6 m € |
| 6 | Swixx Biopharma OÜ | 4,4 m € |
| 7 | Finsupport Services OÜ | 4,4 m € |
| 8 | Tickmill Services OÜ | 3,9 m € |
| 9 | Olensen Management OÜ | 3,8 m € |
| 10 | ThermoNord OÜ | 3,7 m € |
| 11 | BRANDINC JEWELLERY Sp. z o.o. Eesti filiaal | 3,6 m € |
| 12 | R8 Technologies OÜ | 3,5 m € |
| 13 | Orifarm Healthcare OÜ | 3,3 m € |
| 14 | Xolo Teams OÜ | 3,1 m € |
| 15 | Bayer OÜ | 2,9 m € |
| 16 | Merck Sharp & Dohme OÜ | 2,5 m € |
| 17 | Agritrade Europe OÜ | 2,0 m € |
| 18 | Borco machinery OÜ | 2,0 m € |
| 19 | Mapzon OÜ | 1,9 m € |
| 20 | Uponor Infra OÜ | 1,9 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Domains
1 records
Domains
| Domain | Source |
|---|---|
| swixxbiopharma.com |
History and notices
18
| Date | Type | Content |
|---|---|---|
| 02.07.2024 | Entry | Amendment entry |
| 01.07.2024 | Administrative order | |
| 22.09.2023 | Entry | Amendment entry |
| 01.09.2023 | Entry | Amendment entry |
| 12.08.2022 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 09.06.2022 | Entry | Amendment entry |
| 07.04.2022 | Entry | Amendment entry |
| 06.01.2022 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 21.09.2021 | Entry | Amendment entry |
| 11.06.2020 | Entry | Amendment entry |
| 06.06.2019 | Entry | Amendment entry |
| 23.05.2018 | Entry | Amendment entry |
| 19.01.2018 | Entry | Amendment entry |
| 13.02.2017 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 13.01.2016 | Entry | Amendment entry |
| 03.06.2015 | Entry | Amendment entry |
| 28.11.2014 | Entry | Amendment entry |
| 23.10.2014 | Entry | First entry |